Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 247-253

  Kim, Seung Jo ^a   Bae, Seog Nyeon ^a   Kim, Jae Hoon ^a   Kim, Chan Joo ^a   Jung, Jae Keun ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

EMA CO regimen; Gestational trophoblastic tumor; Multivariate analysis; Risk factor; Univariate analysis

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

EID: 0032213033     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5161     Document Type: Article

References (31)

1. Lewis J L Jr. Treatment of metastatic trophoblastic neoplasms. Am J Obstet Gynecol. 136:1979;163-172.
2. Weed J C Jr, Jelovsek F R, Tyrey L. Intensive inpatient therapy and survival in gestational trophoblastic disease. Gynecol Oncol. 15:1983;363-369.
3. Surwit E A, Hammond C B. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol. 55:1980;565-570.
4. Berkowitz R S, Goldstein D P, Bernstein M R. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. Gynecol Oncol. 19:1984;173-181.
5. Begent R HJ, Bagshawe K D. The management of high-risk choriocarcinoma. Semin Oncol. 9:1982;198-203.
6. Jones W B, Cardinale C, Lewis J L Jr. Management of high-risk gestational trophoblastic disease: The Memorial Hospital experience. Int J Gynecol Cancer. 7:1997;27-33.
7. Hertz R, Lewis J L Jr, Lipsett M B. Five years experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol. 82:1961;631-640.
8. Ross G T, Goldstein D P, Hertz R, Lipsett M B, Odell W D. Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in women. Am J Obstet Gynecol. 93:1965;223-229.
9. Hammond C B, Borchert L G, Tyrey L. Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol. 115:1973;451-457.
10. Soper J T, Clarke-Pearson D, Hammond C B. Metastatic gestational trophoblastic disease: Prognostic factors in previously untreated patients. Obstet Gynecol. 71:1988;338-343.
11. Bagshawe K D. Risk and prognostic factors in trophoblastic neoplasia. Cancer. 38:1976;1373-1385.
12. World Health Organization (WHO), Scientific Group, Gestational Trophoblastic Disease, Geneva, WHO, 1983, 1, 81.
13. Bagshawe K D. Treatment of trophoblastic tumours: Recent results. Cancer Res. 62:1977;192-199.
14. Int J Gynecol Obstet. 139:1992;149-150.
15. Lurain J R, Casanova L A, Miller D S, Rademaker A W. Prognostic factors in gestational trophoblastic tumors: A proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol. 164:1991;611-616.
16. Ngan H YS, Lopes A DB, Lauder I J, Martin B H, Wong L C, MA H K. An evaluation of the prognostic factors in metastatic gestational trophoblastic disease. Int J Gynecol Cancer. 4:1994;36-42.
17. Dijkema H E, Aalders J G, De Bruiju H WA, Laurini R N. Risk factors in gestational trophoblastic disease, and consequences for primary treatment. Eur J Obstet Gynecol Reprod Biol. 22:1986;145-152.
18. DuBeshter B. High-risk factors in metastatic gestational trophoblastic neoplasia. J Reprod Med. 36:1991;9-13.
19. Mortakis A E, Braga C A. 'Poor prognosis' metastatic gestational trophoblastic disease: The prognostic significance of the scoring system in predicting chemotherapy failures. Obstet Gynecol. 76:1990;272-277.
20. Dubc-Lissoir J, Sweizig S, Schlaerth J B, Morrow C P. Metastatic gestational trophoblastic disease: A comparison of prognostic classification systems. Gynecol Oncol. 45:1992;40-45.
21. Azab M B, Pejovic M H, Theodore C, George M, Droz J P, Bellet D, Michel G, Amiel J L. Prognostic factors in gestational trophoblastic tumors: A multivariate analysis. Cancer. 62:1988;585-592.
22. Newlands E S, Bagshawe K D, Begent R H, Rustin G J, Holden L. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumours, 1979-1989. Br J Obstet Gynaecol. 98:1991;559-557.
23. Bolis G, Bonazzi C, Landoni F, Managili G, Vergador F, Fanafoni F, Mangioni C. EMA/CO regimen in high-risk GTT. Gynecol Oncol. 31:1988;439-444.
24. DuBeshter B, Berkowitz R S, Goldstein D P, Cramer D W, Bernstein M R. Metastatic gestational trophoblastic disease: Experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol. 69:1987;390-395.
25. Soper J T, Evans A C, Conway M R, Clarke-Pearson D L, Berchuck A, Hammond C B. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol. 84:1994;969-973.
26. Schink J C, Sing D K, Rademaker A W, Miller D S, Lurain J R. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic high-risk gestational trophoblastic disease. Obstet Gynecol. 80:1992;817-820.
27. Soper J T, Evans A C, Clarke-Pearson D L, Berchuck A, Rodriquez G, Hammond C B. Alternating weekly chemotherapy with etoposide-methotrexte-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol. 83:1994;113-117.
28. Rustin G JS, Newlands E S, Begent R HJ, Dent J, Bagshawe K D. Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol. 7:1989;900-903.
29. Weed J C Jr, Woodward K T, Hammond C B. Choriocarcinoma metastatic to the brain: Therapy and prognosis. Semin Oncol. 9:1982;208-212.
30. Lurain J R, Brewer J I, Torok E E, Halpern B. Gestational trophoblastic disease: Treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol. 60:1982;354-360.
31. Kim S J, Jung J K, Kang B C, Bae S N. Multidisciplinary approach in the management of gestational trophoblastic tumour. JPN J Cancer Chemother. 16:1989;1561-1567.